Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
WisdomTree Announces Private Offering of $400 Million of Convertible Senior Notes
-
Lazard Announces Redemption of 3.625% Senior Notes Due March 1, 2027 Issued by Lazard Group LLC
-
V2X Advances National Security Growth with Strategic Acquisition
-
ZipRecruiter Announces Second Quarter 2025 Results
-
Domo Announces Timing of its Second Quarter Fiscal 2026 Earnings Conference Call
-
Enterprise to Participate in Investor Conferences
-
Quince Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
-
GrowGeneration Reports Second Quarter 2025 Financial Results
-
Synchronoss Technologies Reports Second Quarter 2025 Results
-
ACV Announces Second Quarter 2025 Results
-
Life360 Names COO Lauren Antonoff as Chief Executive Officer
-
Sana Biotechnology Reports Second Quarter 2025 Financial Results and Business Updates
-
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Second Quarter 2025 Financial Results on August 14, 2025
-
Metagenomi Appoints Laurence Reid, PhD to its Board of Directors
-
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date July 31, 2025
-
HF Foods Reports Second Quarter 2025 Financial Results
-
Exodus Reports Second Quarter 2025 Results
-
Gaia Reports Second Quarter 2025 Results
-
Taboola to Participate in Upcoming Investor Conferences
-
Peraso Announces Second Quarter 2025 Results
-
Globus Maritime Announces Annual Meeting of Shareholders
-
Crinetics Pharmaceuticals Announces August 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Air Medical Programs Enhance Patient Care State-Wide with Automated CPR Device
-
Quest Resource Holding Corporation Reports Second Quarter 2025 Financial Results
-
Oruka Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
TELA Bio Reports Second Quarter 2025 Financial Results
-
FibroGen Reports Second Quarter 2025 Financial Results and Provides Business Update
-
HighPeak Energy, Inc. Announces Second Quarter 2025 Financial and Operating Results
-
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2025
-
Alpha Tau Announces Second Quarter 2025 Financial Results and Provides Corporate Update
-
Omeros Corporation to Announce Second Quarter Financial Results on August 14, 2025
-
Data I/O Announces Appointment of Charles DiBona as Chief Financial Officer
-
Denali Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights
-
Fluence Energy, Inc. Reports Third Quarter 2025 Results; Reaffirms Fiscal Year 2025 Guidance
-
Mercury Systems Reports Fourth Quarter and Fiscal 2025 Results
-
Standard BioTools Reports Second Quarter 2025 Financial Results
-
Harrow Announces Second-Quarter 2025 Financial Results
-
Forward Air Corporation Reports Second Quarter 2025 Results
-
Xenon Reports Second Quarter 2025 Financial Results & Business Update
-
Laxxon Medical Announces Successful Product Development Milestone with Novel Oral Modified-Release Formulation of Veru’s Enobosarm, Utilizing Laxxon’s SPID®-Technology
-
Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress
-
Atara Biotherapeutics Announces Second Quarter Financial Results and Operational Progress
-
Dynex Capital, Inc. Declares Monthly Common Stock Dividend of $0.17 Per Common Share for August 2025
-
Backblaze to Showcase AI-Powered Media Archive Solutions in Partnership Webinar with TwelveLabs
-
MindMed Announces New Employee Inducement Grants
-
Xenon Reports Second Quarter 2025 Financial Results & Business Update
-
Septerna Highlights Business Progress and Reports Second Quarter 2025 Financial Results
-
Gyre Therapeutics Reports Second Quarter 2025 and Year-to-Date Financial Results and Provides Business and Leadership Update
-
Plug Power Second Quarter 2025 Highlights
-
Gevo Reports Second Quarter 2025 Financial Results

